https://www.prnewswire.com/in/news-releases/galimedix-accelerating-development-of-its-next-generation-oral-anti-amyloid-beta-drug-gal-201-for-alzheimer-s-disease-892589521.html
Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for...
/PRNewswire/ -- Galimedix, Inc., a clinical-stage biopharmaceutical company focused on developing new small-molecule medicines for patients suffering from...